Annual CFF
-$7.42 M
-$5.36 M-260.10%
December 31, 2023
Summary
- As of February 8, 2025, CPIX annual cash flow from financing activities is -$7.42 million, with the most recent change of -$5.36 million (-260.10%) on December 31, 2023.
- During the last 3 years, CPIX annual CFF has fallen by -$308.40 thousand (-4.33%).
- CPIX annual CFF is now -111.05% below its all-time high of $67.18 million, reached on December 31, 2009.
Performance
CPIX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$536.80 K
-$227.20 K-73.39%
September 30, 2024
Summary
- As of February 8, 2025, CPIX quarterly cash flow from financing activities is -$536.80 thousand, with the most recent change of -$227.20 thousand (-73.39%) on September 30, 2024.
- Over the past year, CPIX quarterly CFF has increased by +$950.30 thousand (+63.90%).
- CPIX quarterly CFF is now -100.81% below its all-time high of $66.51 million, reached on September 30, 2009.
Performance
CPIX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$88.20 K
+$345.80 K+134.24%
September 30, 2024
Summary
- As of February 8, 2025, CPIX TTM cash flow from financing activities is $88.20 thousand, with the most recent change of +$345.80 thousand (+134.24%) on September 30, 2024.
- Over the past year, CPIX TTM CFF has increased by +$7.51 million (+101.19%).
- CPIX TTM CFF is now -99.87% below its all-time high of $67.18 million, reached on December 31, 2009.
Performance
CPIX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CPIX Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -260.1% | +63.9% | +101.2% |
3 y3 years | -4.3% | -240.2% | +101.7% |
5 y5 years | -204.0% | +64.8% | +101.7% |
CPIX Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -260.1% | at low | -113.7% | +83.6% | -96.3% | +100.9% |
5 y | 5-year | -260.1% | at low | -113.7% | +83.6% | -96.3% | +100.9% |
alltime | all time | -111.0% | +40.1% | -100.8% | +91.1% | -99.9% | +100.7% |
Cumberland Pharmaceuticals Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$536.80 K(+73.4%) | $88.20 K(-134.2%) |
Jun 2024 | - | -$309.60 K(-112.8%) | -$257.60 K(-92.0%) |
Mar 2024 | - | $2.42 M(-262.8%) | -$3.22 M(-56.6%) |
Dec 2023 | -$7.42 M(+260.1%) | -$1.49 M(+68.5%) | -$7.42 M(-14.8%) |
Sep 2023 | - | -$882.60 K(-73.1%) | -$8.72 M(-11.3%) |
Jun 2023 | - | -$3.28 M(+84.1%) | -$9.83 M(+26.6%) |
Mar 2023 | - | -$1.78 M(-36.0%) | -$7.76 M(+276.3%) |
Dec 2022 | -$2.06 M(-42.0%) | -$2.78 M(+39.7%) | -$2.06 M(>+9900.0%) |
Sep 2022 | - | -$1.99 M(+64.8%) | -$16.30 K(-100.7%) |
Jun 2022 | - | -$1.21 M(-130.8%) | $2.36 M(+41.8%) |
Mar 2022 | - | $3.92 M(-632.9%) | $1.66 M(-146.8%) |
Dec 2021 | -$3.55 M(-50.1%) | -$735.30 K(-292.0%) | -$3.55 M(-32.3%) |
Sep 2021 | - | $383.00 K(-120.1%) | -$5.25 M(-19.8%) |
Jun 2021 | - | -$1.90 M(+46.6%) | -$6.55 M(-5.3%) |
Mar 2021 | - | -$1.30 M(-46.6%) | -$6.91 M(-2.9%) |
Dec 2020 | -$7.12 M(+40.1%) | -$2.43 M(+165.5%) | -$7.12 M(+14.6%) |
Sep 2020 | - | -$915.50 K(-59.6%) | -$6.21 M(-10.6%) |
Jun 2020 | - | -$2.27 M(+50.8%) | -$6.95 M(+29.5%) |
Mar 2020 | - | -$1.50 M(-1.5%) | -$5.36 M(+5.6%) |
Dec 2019 | -$5.08 M(-171.2%) | -$1.53 M(-7.5%) | -$5.08 M(-233.2%) |
Sep 2019 | - | -$1.65 M(+140.8%) | $3.81 M(-24.2%) |
Jun 2019 | - | -$685.00 K(-43.9%) | $5.03 M(+5.2%) |
Mar 2019 | - | -$1.22 M(-116.6%) | $4.78 M(-33.0%) |
Dec 2018 | $7.14 M(+266.5%) | $7.37 M(-1806.4%) | $7.14 M(+903.5%) |
Sep 2018 | - | -$431.80 K(-53.8%) | $711.30 K(-46.9%) |
Jun 2018 | - | -$935.00 K(-182.3%) | $1.34 M(-63.1%) |
Mar 2018 | - | $1.14 M(+20.7%) | $3.63 M(+86.4%) |
Dec 2017 | $1.95 M(-269.8%) | $941.50 K(+378.4%) | $1.95 M(+201.6%) |
Sep 2017 | - | $196.80 K(-85.5%) | $645.70 K(+67.1%) |
Jun 2017 | - | $1.36 M(-348.3%) | $386.30 K(-235.2%) |
Mar 2017 | - | -$545.90 K(+51.4%) | -$285.80 K(-75.1%) |
Dec 2016 | -$1.15 M(-77.9%) | -$360.50 K(+475.9%) | -$1.15 M(-39.1%) |
Sep 2016 | - | -$62.60 K(-109.2%) | -$1.88 M(-36.7%) |
Jun 2016 | - | $683.20 K(-148.5%) | -$2.98 M(-39.5%) |
Mar 2016 | - | -$1.41 M(+28.2%) | -$4.92 M(-5.3%) |
Dec 2015 | -$5.19 M | -$1.10 M(-5.1%) | -$5.19 M(+1.9%) |
Sep 2015 | - | -$1.16 M(-8.1%) | -$5.10 M(+7.7%) |
Jun 2015 | - | -$1.26 M(-25.1%) | -$4.73 M(+81.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2015 | - | -$1.68 M(+68.0%) | -$2.61 M(+57.1%) |
Dec 2014 | -$1.66 M(-81.8%) | -$1.00 M(+26.2%) | -$1.66 M(-71.6%) |
Sep 2014 | - | -$792.90 K(-191.9%) | -$5.84 M(-20.3%) |
Jun 2014 | - | $862.70 K(-217.9%) | -$7.33 M(-12.5%) |
Mar 2014 | - | -$731.60 K(-85.9%) | -$8.38 M(-8.5%) |
Dec 2013 | -$9.15 M(+117.6%) | -$5.18 M(+127.0%) | -$9.15 M(+153.6%) |
Sep 2013 | - | -$2.28 M(+1147.7%) | -$3.61 M(+11.6%) |
Jun 2013 | - | -$183.00 K(-87.8%) | -$3.23 M(-25.7%) |
Mar 2013 | - | -$1.51 M(-515.5%) | -$4.35 M(+3.5%) |
Dec 2012 | -$4.21 M(+17.6%) | $362.30 K(-119.0%) | -$4.21 M(-30.1%) |
Sep 2012 | - | -$1.91 M(+46.6%) | -$6.02 M(+11.6%) |
Jun 2012 | - | -$1.30 M(-4.3%) | -$5.40 M(+32.4%) |
Mar 2012 | - | -$1.36 M(-6.2%) | -$4.07 M(+13.8%) |
Dec 2011 | -$3.58 M(-71.1%) | -$1.45 M(+13.0%) | -$3.58 M(+382.6%) |
Sep 2011 | - | -$1.28 M(-6684.1%) | -$741.60 K(-86.5%) |
Jun 2011 | - | $19.50 K(-102.3%) | -$5.48 M(-30.2%) |
Mar 2011 | - | -$864.60 K(-162.3%) | -$7.85 M(-36.7%) |
Dec 2010 | -$12.39 M(-118.4%) | $1.39 M(-123.1%) | -$12.39 M(-2.1%) |
Sep 2010 | - | -$6.02 M(+156.1%) | -$12.65 M(-121.1%) |
Jun 2010 | - | -$2.35 M(-56.5%) | $59.87 M(-3.1%) |
Mar 2010 | - | -$5.40 M(-582.1%) | $61.77 M(-8.1%) |
Dec 2009 | $67.18 M(-1380.1%) | $1.12 M(-98.3%) | $67.18 M(+4.0%) |
Sep 2009 | - | $66.51 M(<-9900.0%) | $64.58 M(-2801.0%) |
Jun 2009 | - | -$456.40 K(-4757.1%) | -$2.39 M(-47.0%) |
Mar 2009 | - | $9800.00(-100.7%) | -$4.51 M(-14.0%) |
Dec 2008 | -$5.25 M(+34.4%) | -$1.48 M(+219.7%) | -$5.25 M(+11.3%) |
Sep 2008 | - | -$463.30 K(-82.0%) | -$4.72 M(-21.3%) |
Jun 2008 | - | -$2.58 M(+255.1%) | -$5.99 M(+46.5%) |
Mar 2008 | - | -$725.90 K(-23.5%) | -$4.09 M(+4.8%) |
Dec 2007 | -$3.90 M(-176.4%) | -$948.90 K(-45.5%) | -$3.90 M(+16.5%) |
Sep 2007 | - | -$1.74 M(+158.0%) | -$3.35 M(+62.1%) |
Jun 2007 | - | -$675.00 K(+25.3%) | -$2.07 M(-145.8%) |
Mar 2007 | - | -$538.70 K(+36.4%) | $4.51 M(-11.7%) |
Dec 2006 | $5.11 M(+74.8%) | -$395.00 K(-13.8%) | $5.11 M(-7.2%) |
Sep 2006 | - | -$458.30 K(-107.8%) | $5.50 M(-7.7%) |
Jun 2006 | - | $5.90 M(+9837.7%) | $5.96 M(>+9900.0%) |
Mar 2006 | - | $59.40 K | $59.40 K |
Dec 2005 | $2.92 M | - | - |
FAQ
- What is Cumberland Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals annual CFF year-on-year change?
- What is Cumberland Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals quarterly CFF year-on-year change?
- What is Cumberland Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cumberland Pharmaceuticals?
- What is Cumberland Pharmaceuticals TTM CFF year-on-year change?
What is Cumberland Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of CPIX is -$7.42 M
What is the all time high annual CFF for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high annual cash flow from financing activities is $67.18 M
What is Cumberland Pharmaceuticals annual CFF year-on-year change?
Over the past year, CPIX annual cash flow from financing activities has changed by -$5.36 M (-260.10%)
What is Cumberland Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of CPIX is -$536.80 K
What is the all time high quarterly CFF for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high quarterly cash flow from financing activities is $66.51 M
What is Cumberland Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, CPIX quarterly cash flow from financing activities has changed by +$950.30 K (+63.90%)
What is Cumberland Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of CPIX is $88.20 K
What is the all time high TTM CFF for Cumberland Pharmaceuticals?
Cumberland Pharmaceuticals all-time high TTM cash flow from financing activities is $67.18 M
What is Cumberland Pharmaceuticals TTM CFF year-on-year change?
Over the past year, CPIX TTM cash flow from financing activities has changed by +$7.51 M (+101.19%)